CORT Form 144: 20,000 Shares Planned Sale

Corcept Therapeutics: Rule 144 notice of proposed sale of common stock.

Rhea-AI Filing Summary

Corcept Therapeutics: Rule 144 notice of proposed sale of common stock. The filing lists a planned sale of 20,000 common shares on 03/04/2026 by Stifel Nicolaus & Company Inc. via a stock option exercise for cash. The filing also records prior sales by William Guyer of 20,000 shares on 02/03/2026 for $817,333.00 and 20,000 shares on 01/06/2026 for $703,655.00.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CORT Form 144 disclose about planned sales?

The filing discloses a planned sale of 20,000 common shares on 03/04/2026 by Stifel Nicolaus & Company Inc. The method listed is a stock option exercise and the consideration type is cash.

Who sold shares of CORT in the prior three months according to the filing?

The filing shows William Guyer sold 20,000 shares on 02/03/2026 for $817,333.00 and 20,000 shares on 01/06/2026 for $703,655.00, as reported in the Form 144 excerpt.

What selling method is specified for the 03/04/2026 transaction in CORT's Form 144?

The 03/04/2026 transaction is specified as a Stock Option Exercise resulting in a planned sale of 20,000 common shares, with proceeds to be received in cash, per the filing excerpt.

Which broker-dealer is named in the CORT Form 144 for the proposed sale?

The filing names Stifel Nicolaus & Company Inc. at 501 N. Broadway, St. Louis, MO, as the broker-dealer associated with the planned sale of 20,000 common shares on 03/04/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001879013
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORCEPT THERAPEUTICS INC
SEC File Number	000-50679
Address of Issuer	101 REDWOOD SHORES PARKWAY REDWOOD CITY CALIFORNIA 94065
Phone	650.688.8803
Name of Person for Whose Account the Securities are To Be Sold	Guyer William
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Stifel Nicolaus & Company Inc. 501 N. Broadway St. Louis MO 63102	20000	705600.00	106370000	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/04/2026	Stock Option Exercise	Corcept Therapeutics Inc.			20000	03/04/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	02/03/2026	20000	817333.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	01/06/2026	20000	703655.00

144: Remarks and Signature

Remarks
Date of Notice	03/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/27/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Toni Dobel, as a duly authorized representative of STIFEL, as attorney-in-fact for William Guyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)